Skip to main content

H R 3 (2019)

Summary:

Directs the federal government to negotiate drug prices for Medicare directly with pharmaceutical companies and caps out-of-pocket costs for Medicare part D enrollees.

Want hearing dates, vote records or the full bill text? See more on the Statehouse website https://www.govtrack.us/congress/bills/116/hr3
Browse related articles and bills:
Thank you to our sponsors and donors